Veru ROA 2010-2023 | VERU
Current and historical return on assets (ROA) values for Veru (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Veru ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $-0.06B | $0.08B | -95.82% |
| 2023-09-30 | $-0.09B | $0.05B | -131.47% |
| 2023-06-30 | $-0.13B | $0.06B | -135.85% |
| 2023-03-31 | $-0.14B | $0.07B | -120.00% |
| 2022-12-31 | $-0.12B | $0.10B | -80.98% |
| 2022-09-30 | $-0.08B | $0.14B | -51.79% |
| 2022-06-30 | $-0.05B | $0.16B | -26.90% |
| 2022-03-31 | $-0.03B | $0.17B | -15.36% |
| 2021-12-31 | $-0.02B | $0.17B | -9.00% |
| 2021-09-30 | $0.01B | $0.18B | 4.58% |
| 2021-06-30 | $-0.00B | $0.18B | -0.82% |
| 2021-03-31 | $-0.00B | $0.18B | -1.08% |
| 2020-12-31 | $0.00B | $0.07B | 1.63% |
| 2020-09-30 | $-0.02B | $0.05B | -33.33% |
| 2020-06-30 | $-0.01B | $0.07B | -17.39% |
| 2020-03-31 | $-0.01B | $0.06B | -18.26% |
| 2019-12-31 | $-0.01B | $0.06B | -24.30% |
| 2019-09-30 | $-0.01B | $0.05B | -22.75% |
| 2019-06-30 | $-0.02B | $0.05B | -33.17% |
| 2019-03-31 | $-0.02B | $0.05B | -43.14% |
| 2018-12-31 | $-0.02B | $0.05B | -41.71% |
| 2018-09-30 | $-0.02B | $0.05B | -45.71% |
| 2018-06-30 | $-0.02B | $0.05B | -38.71% |
| 2018-03-31 | $-0.01B | $0.06B | -25.34% |
| 2017-12-31 | $-0.01B | $0.05B | -21.82% |
| 2017-09-30 | $-0.01B | $0.06B | -15.65% |
| 2017-06-30 | $-0.01B | $0.06B | -11.21% |
| 2017-03-31 | $-0.00B | $0.06B | -8.08% |
| 2016-12-31 | $-0.00B | $0.06B | -4.42% |
| 2016-09-30 | $0.00B | $0.04B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 7.64% |
| 2016-03-31 | $0.00B | $0.04B | 7.84% |
| 2015-12-31 | $0.01B | $0.04B | 13.42% |
| 2015-09-30 | $0.01B | $0.04B | 13.99% |
| 2015-06-30 | $0.00B | $0.04B | 8.70% |
| 2015-03-31 | $0.00B | $0.04B | 8.96% |
| 2014-12-31 | $0.00B | $0.03B | 3.05% |
| 2014-09-30 | $0.00B | $0.03B | 3.01% |
| 2014-06-30 | $0.01B | $0.03B | 26.47% |
| 2014-03-31 | $0.01B | $0.03B | 26.67% |
| 2013-12-31 | $0.01B | $0.04B | 35.56% |
| 2013-09-30 | $0.02B | $0.04B | 46.15% |
| 2013-06-30 | $0.02B | $0.03B | 51.20% |
| 2013-03-31 | $0.02B | $0.03B | 61.02% |
| 2012-12-31 | $0.02B | $0.03B | 62.96% |
| 2012-09-30 | $0.02B | $0.03B | 64.65% |
| 2012-06-30 | $0.01B | $0.03B | 59.09% |
| 2012-03-31 | $0.01B | $0.02B | 51.28% |
| 2011-12-31 | $0.01B | $0.02B | 45.07% |
| 2011-09-30 | $0.01B | $0.02B | 29.85% |
| 2011-06-30 | $0.01B | $0.02B | 36.36% |
| 2011-03-31 | $0.01B | $0.02B | 36.92% |
| 2010-12-31 | $0.01B | $0.02B | 49.23% |
| 2010-09-30 | $0.01B | $0.02B | 44.44% |
| 2010-06-30 | $0.00B | $0.01B | 18.75% |
| 2010-03-31 | $0.00B | $0.02B | 24.62% |
| 2009-12-31 | $0.00B | $0.02B | 25.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.193B | $0.016B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.079B | 23.71 |
| Stryker (SYK) | United States | $127.496B | 30.54 |
| Medtronic (MDT) | Ireland | $114.087B | 16.15 |
| Boston Scientific (BSX) | United States | $109.519B | 34.88 |
| EssilorLuxottica (ESLOY) | France | $102.905B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.259B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.109B | 30.15 |
| Koninklijke Philips (PHG) | Netherlands | $25.984B | 20.13 |
| Terumo (TRUMY) | Japan | $25.953B | 36.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.724B | 15.79 |
| Baxter (BAX) | United States | $17.963B | 12.77 |
| Insulet (PODD) | United States | $13.116B | 58.16 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.406B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.382B | 27.41 |
| BellRing Brands (BRBR) | United States | $7.488B | 35.22 |
| Lantheus Holdings (LNTH) | United States | $5.522B | 13.76 |
| Haemonetics (HAE) | United States | $4.862B | 24.05 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.066B | 12.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 15.36 |
| Envista Holdings (NVST) | United States | $3.185B | 13.14 |
| Neogen (NEOG) | United States | $2.933B | 28.21 |
| QuidelOrtho (QDEL) | United States | $2.868B | 15.92 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.735B | 54.17 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.534B | 22.36 |
| Agios Pharmaceuticals (AGIO) | United States | $1.950B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.761B | 51.61 |
| Warby Parker (WRBY) | United States | $1.639B | 0.00 |
| InMode (INMD) | Israel | $1.550B | 8.24 |
| Owens & Minor (OMI) | United States | $1.424B | 12.41 |
| AdaptHealth (AHCO) | United States | $1.329B | 9.88 |
| National Vision Holdings (EYE) | United States | $1.240B | 39.45 |
| AtriCure (ATRC) | United States | $1.101B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.913B | 0.00 |
| Evolus (EOLS) | United States | $0.851B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.745B | 15.86 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| Valneva SE (VALN) | France | $0.618B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| PetIQ (PETQ) | United States | $0.588B | 19.20 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.494B | 30.91 |
| Jin Medical (ZJYL) | China | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.464B | 39.58 |
| Aurora Cannabis (ACB) | Canada | $0.403B | 0.00 |
| Cerus (CERS) | United States | $0.364B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.364B | 11.71 |
| Biote (BTMD) | United States | $0.357B | 8.21 |
| Zynex (ZYXI) | United States | $0.346B | 47.30 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.35 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.264B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.49 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.171B | 82.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.134B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 8.28 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.085B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.025B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |